These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33395080)

  • 1. Cardiovascular implications and complications of the coronavirus disease-2019 pandemic: a world upside down.
    Manolis AS; Manolis TA; Manolis AA; Melita H
    Curr Opin Cardiol; 2021 Mar; 36(2):241-251. PubMed ID: 33395080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the renin-angiotensin-aldosterone-SARS-CoV axis: a comprehensive review.
    Ingraham NE; Barakat AG; Reilkoff R; Bezdicek T; Schacker T; Chipman JG; Tignanelli CJ; Puskarich MA
    Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32341103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
    Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
    Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The COVID-19 pandemic, heart and cardiovascular diseases: What we have learned.
    Piątek Z; Gać P; Poręba M
    Dent Med Probl; 2021; 58(2):219-227. PubMed ID: 34038630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 and renin-angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) - Is there any scientific evidence for controversy?
    Aleksova A; Ferro F; Gagno G; Cappelletto C; Santon D; Rossi M; Ippolito G; Zumla A; Beltrami AP; Sinagra G
    J Intern Med; 2020 Oct; 288(4):410-421. PubMed ID: 32459372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injury.
    Sarzani R; Giulietti F; Di Pentima C; Giordano P; Spannella F
    Am J Physiol Lung Cell Mol Physiol; 2020 Aug; 319(2):L325-L336. PubMed ID: 32639866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular Pharmacology in the Time of COVID-19: A Focus on Angiotensin-Converting Enzyme 2.
    Buckley LF; Cheng JWM; Desai A
    J Cardiovasc Pharmacol; 2020 Jun; 75(6):526-529. PubMed ID: 32301766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiovascular implications of SARS-CoV-2 infection: A literature review].
    García-Saavedra MB; Rosales-Gutiérrez RR; Valverde E; Chumbes-Aguirre M; Alvarado R; Polo R; Azañero R; Chávez C
    Medwave; 2020 Aug; 20(7):e8008. PubMed ID: 32877391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular Complications Associated with COVID-19 and Potential Therapeutic~Strategies.
    Samidurai A; Das A
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32947927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of Angiotensin-Converting Enzyme 2: A Potential Target to Prevent COVID-19?
    Hu Y; Liu L; Lu X
    Front Endocrinol (Lausanne); 2021; 12():725967. PubMed ID: 34745001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenge of post-COVID era: management of cardiovascular complications in asymptomatic carriers of SARS-CoV-2.
    Gupta S; Mitra A
    Heart Fail Rev; 2022 Jan; 27(1):239-249. PubMed ID: 33426593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [COVID-19 and cardiovascular diseases].
    Chazova IE; Mironova OI
    Ter Arkh; 2020 Oct; 92(9):4-7. PubMed ID: 33346424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease.
    Tomasoni D; Italia L; Adamo M; Inciardi RM; Lombardi CM; Solomon SD; Metra M
    Eur J Heart Fail; 2020 Jun; 22(6):957-966. PubMed ID: 32412156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 and the cardiovascular system.
    Hafiane A
    Clin Chim Acta; 2020 Nov; 510():311-316. PubMed ID: 32681935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular aspects of COVID-19.
    Kurz DJ; Eberli FR
    Swiss Med Wkly; 2020 Dec; 150():w20417. PubMed ID: 33382450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Science Underlying COVID-19: Implications for the Cardiovascular System.
    Liu PP; Blet A; Smyth D; Li H
    Circulation; 2020 Jul; 142(1):68-78. PubMed ID: 32293910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for Use or Disuse of Renin-Angiotensin System Modulators in Patients Having COVID-19 With an Underlying Cardiorenal Disorder.
    Sankrityayan H; Kale A; Sharma N; Anders HJ; Gaikwad AB
    J Cardiovasc Pharmacol Ther; 2020 Jul; 25(4):299-306. PubMed ID: 32351121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19.
    Kuba K; Yamaguchi T; Penninger JM
    Front Immunol; 2021; 12():732690. PubMed ID: 35003058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronavirus disease 2019 and cardiovascular implications.
    Frattini S; Maccagni G; Italia L; Metra M; Danzi GB
    J Cardiovasc Med (Hagerstown); 2020 Oct; 21(10):725-732. PubMed ID: 32858623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.